Then, Prakash offered a rundown of how advocacy efforts in Texas had curtailed many PBM practices. In 2017, Senate Bill (SB) 680 limited insurers’ use of step therapy, requiring protocols to be ...

CAR-T cell therapy has demonstrated extraordinary success when used to treat hematologic malignancies. Nevertheless, there are several barriers that prevent this achievement from being applied to ...

This paper presents a transformative Robot-Enhanced Therapy (RET) framework, leveraging an intricate amalgamation of an Adaptive Boosted 3D biomarker approach and Saliency Maps generated through ...

Hope Biosciences’ proprietary cell therapy product has been previously employed in multiple conditions similar or related to JIA, including rheumatoid arthritis, chronic musculoskeletal pain ...

A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This breakthrough procedure is still experimental but shows immense promise for those ...

focusing on pro-invasive cell volume reduction in ductal carcinoma in situ (DCIS). Crowding specifically enhanced invasiveness in high-grade DCIS cells through significant volume reduction compared to ...

As part of a clinical trial, the girl received CAR-T cell therapy, a treatment that requires removing some of a patient’s immune cells and programming them to target and kill cancer cells before ...

School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea ...